Biotech

  • Mechanical forces could help develop treatments for heart disease

    A team of engineers and biologists at the University of Colorado Boulder have discovered new insights into how mechanical forces guide the development of cells. The findings could one day help researchers develop new treatments for heart disease in humans and develop more authentic artificial tissue in the lab. Corey Neu, professor of biomedical engineering [...]

  • This week in health tech: December 12, 2021

    In today’s Health Tech World weekly roundup, we bring you research updates, investment news and interviews from around the world. This week, a team of scientists discovered that computer-designed, hand-assembled organisms can reproduce, the Competition and Markets Authority (CMA) raised concerns with Randox about some of its terms and conditions. And researchers at the University [...]

  • ‘Landmark’ biomedical engineering hub opens in London

    A new London research facility will work to advance life-changing medical technologies and treatments. The Sir Michael Uren Hub has opened at Imperial College London’s White City Campus. Designed as a multidisciplinary collaborative facility, the Sir Michael Uren Hub provides space for Imperial’s researchers, engineers, scientists and clinicians to work alongside one another to tackle [...]

  • MIMEDX outlines long-term value creation strategy at Virtual Investor Day

    MiMedx Group, a transformational placental biologics company, will provide details about near and long-term growth opportunities for its multi-modal placental tissue platform at today’s (December 7) virtual Investor Day, which begins at 9:00 a.m. ET. The Investor Day will provide updates by company leadership, third-party experts and key opinion leaders on the musculoskeletal late-stage pipeline [...]

  • Bionic eye could be trialled on humans

    Biomedical researchers at the University of Sydney and UNSW say they have developed a bionic eye that is safe and stable for long-term implantation, paving the way towards human trials. The Phoenix99 Bionic Eye is an implantable system, designed to restore a form of vision to patients living with severe vision impairment and blindness caused [...]

  • Debate: The great advanced therapies talent drive

    Experts gathered at the Advanced Therapies Integrates 2021 conference recently to debate solutions to challenges facing the sector. Here they focus on how to develop the tech talent needed to build the next generation of vital products. The event was chaired by James Strachan, editor of The Cell and Gene Curator newsletter, who kicked off [...]

  • Microscope uses photonics to gain insights into ‘superbugs’

    Technology platform Photonics21 is building a super-resolution microscope that uses laser light to study the inner workings of superbugs. Scientists say the NanoVIB microscope will allow users to look into bacteria, such as Streptococcus Pneumoniae, at a molecular-scale resolution, showing up objects smaller than 10,000th the thickness of a sheet of paper, to gain new insights [...]

  • Biotech entrepreneur becomes CEO of UK glycan tech firm

    UK biotech firm Iceni Diagnostics has appointed a new CEO as the company prepares to bring its products to market. Biotechnology entrepreneur, Martin Stocks, helped secure the founding investment in the pioneering glycoscience company seven years ago, and now picks up the reins with immediate effect. Dr Stocks spent a period at Yale University in [...]

  • Video debate: The future of biomanufacturing

    Health Tech World recently hosted a roundtable featuring leading experts from across the biomanufacturing sector. The wide-ranging discussion, held in partnership with Invest Tees Valley, covered the challenges and opportunities of UK biomanufacturing and the barriers that must be addressed in fulfilling the sector’s potential. Much of the focus of the discussion was on Tees [...]

  • ‘It’s a risky, but important new direction to explore’

    HT World reports on the possibilities of continuous viral evolution, in conversation with Dr Benjamin Bartelle of Arizona State University.